Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-235,217
Closed -$12.2M 1791
2022
Q1
$12.2M Buy
235,217
+186,939
+387% +$9.65M 0.08% 203
2021
Q4
$2.85M Buy
48,278
+19,244
+66% +$1.1M 0.02% 662
2021
Q3
$1.6M Sell
29,034
-18,351
-39% -$1.02M 0.01% 833
2021
Q2
$2.43M Buy
47,385
+27,060
+133% +$1.4M 0.02% 688
2021
Q1
$1.04M Buy
20,325
+14,234
+234% +$782K 0.01% 892
2020
Q4
$335K Sell
6,091
-1,448
-19% -$77.3K ﹤0.01% 1252
2020
Q3
$418K Sell
7,539
-63,945
-89% -$3.32M ﹤0.01% 1025
2020
Q2
$3.27K Buy
+71,484
New +$3.2M 0.04% 385
2020
Q1
Sell
-162,470
Closed -$5.82M 2554
2019
Q4
$5.82M Sell
162,470
-101,806
-39% -$3.78M 0.05% 454
2019
Q3
$9.2M Buy
264,276
+46,752
+21% +$1.8M 0.07% 252
2019
Q2
$9.36M Sell
217,524
-81,106
-27% -$3.36M 0.07% 245
2019
Q1
$12.8M Sell
298,630
-169,739
-36% -$6.83M 0.11% 157
2018
Q4
$16.9M Buy
468,369
+289,794
+162% +$10.8M 0.14% 108
2018
Q3
$7.17M Sell
178,575
-188,446
-51% -$7.53M 0.05% 390
2018
Q2
$14.2M Buy
367,021
+350,733
+2,153% +$12.9M 0.08% 178
2018
Q1
$558K Buy
+16,288
New +$572K ﹤0.01% 1444
2017
Q3
Sell
-41,651
Closed -$1.48M 2566
2017
Q2
$1.48M Buy
41,651
+13,727
+49% +$464K 0.01% 1094
2017
Q1
$858K Buy
+27,924
New +$861K 0.01% 1358

Other funds holding QGEN

Jefferies Group's QGEN Position: Q2 2022 in Review

Jefferies Group sold out of Qiagen (QGEN) in Q2 2022, closing a stake of 235,217 shares — an estimated $12.2M sold.

Jefferies Group first reported a position in QGEN in Q1 2017 and held it in 18 quarters. The position peaked at $16.9M in Q4 2018. 287 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.

  • Jefferies Group reported no remaining Qiagen position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 235,217 Qiagen shares in Q2 2022, an estimated $12.2M.
  • Jefferies Group first reported a position in Qiagen in Q1 2017 and held it in 18 quarters.
  • Jefferies Group's Qiagen position peaked at $16.9M in Q4 2018.
  • 287 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.